Index of reports
> Cases with Pruritus (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Betadine (Povidone-Iodine Ophthalmic) where reactions include pruritus. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Betadine side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31
Patient: 71 year old female
Reactions: Pruritus, Rash Erythematous, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Isosorbide Dinitrate
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Tocopheryl Acetate
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Isoptin
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Repaglinide
Dosage: 1.5 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
End date: 2009-08-28
Aspirin
Dosage: 160 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
Amlodipine Besylate
Dosage: 10 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
Plavix
Dosage: 75 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
Metformin HCL
Dosage: 500 mg, 3x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-08-22
End date: 2009-08-28
Betadine
Dosage: unk
Administration route: Topical
Indication: Infection Prophylaxis
Start date: 2009-08-21
End date: 2009-08-21
Visipaque
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Lovenox
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Solu-Medrol
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Other drugs received by patient: Daflon; Januvia; Ebastine; Havlane; Polyethylene Glycol; Desloratadine; Nordaz
Possible Betadine side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31
Patient: 71 year old female
Reactions: Pruritus, Idiopathic Urticaria, Rash Erythematous, Urticaria, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metformin HCL
Dosage: 500 mg, tid, unk
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-08-22
End date: 2009-08-28
Heparin
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Visipaque
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Betadine
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Repaglinide
Dosage: 0.5 mg, tid , unk
Administration route: Oral
Start date: 2009-08-22
End date: 2009-08-28
Aspirin
Dosage: 160.000000 mg, qd, unk
Administration route: Oral
Start date: 2009-08-22
Clopidogrel Bisulfate
Dosage: 75.000000 mg, qd, unk
Administration route: Oral
Start date: 2009-08-22
Tocopheryl Acetate
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Isoptin
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Solu-Medrol
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Amlodipine Besylate
Dosage: 10 mg, qd , unk
Administration route: Oral
Start date: 2009-08-22
Other drugs received by patient: Daflon; Ebastine; Loprazolam Mesilate; Macrogol
|